Latest Product Development News

Comms Group has agreed to divest its onPlatinum IT managed services division for A$30 million, a move that simplifies its business and boosts balance sheet strength ahead of FY27.

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

ArborGen Holdings reported a solid FY26 with record revenue driven by Brazil expansion and a 31% EBITDA increase, offsetting a challenging US market. Leadership changes and operational discipline mark the company’s path forward.

EROAD Limited reported stable FY26 revenue of NZD 195 million amid a $134.7 million North American impairment, unveiling a strategic reset centred on ANZ growth and its expanding electronic Road User Charges platform.

TZ Limited (ASX:TZL) has launched a 1-for-4 non-renounceable entitlement offer priced at 3 cents per share, aiming to raise approximately $2.58 million to reduce debt and fund growth initiatives.

Spenda Limited has pushed back the closing date for its retail entitlement offer by five days, aiming to complete a critical $8.545 million capital raise to support its turnaround plan and reduce debt.

ClearVue Technologies has boosted its capital raising to $6.25 million, with significant board participation and revised loan terms, while its Gen 3 Vision Glass secures crucial EN 1279-5 certification.

TZ Limited has secured $0.50 million through a placement of 16.7 million shares at 3 cents each, using its 10% placement capacity, and is launching a 1-for-4 entitlement offer to raise an additional $2.58 million.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

ECS Botanics has commenced commercial sales of Gelonoidz #20, its first Australian-grown Terphogz cultivar, marking a key step in expanding its premium medicinal cannabis portfolio with plans for more cultivars in FY27.

CONNEQT Health has raised A$5.5 million through a two-tranche placement at a 15.4% discount, backed by key shareholders, to accelerate its commercial expansion and product development.

Green360 Technologies has launched MKX Ultra Fine, a new metakaolin product designed to substitute silica fume in high-strength concrete, addressing critical supply constraints in supplementary cementitious materials.